Shareholder Investigation Announced Against AN2 Therapeutics, Inc.
Purcell & Lefkowitz LLP has announced an investigation into potential fiduciary duty breaches by the directors of AN2 Therapeutics (NASDAQ: ANTX). The firm is seeking shareholders to join the case and provide information. This could lead to legal action if misconduct is found, potentially impacting investor confidence.
Topics: corporate governance fiduciary duties securities fraud